Lilly(Eli) & Company
NYSE: LLY
$887.16
+$1.61 (+0.2%)
Closing Price on October 4, 2024
LLY Articles
Eli Lilly reported disappointing first-quarter 2014 results before markets opened Thursday, due in part to the impact of U.S. patent expirations for Cymbalta and Evista. Shares were up in premarket...
Published:
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Thursday, April 3, 2014. They include Apple, Intel, Chevron, Exxon, Qualcomm and Citigroup.
Published:
The chief strategist at Piper Jaffray released his report for March. It details how the second and third quarters typically behave in the mid-term years after a solid first quarter. Here are the top...
Published:
In a new research report, Cowen analysts posted a list of some of the top new datapoints cited at the Cowen 2014 Healthcare Conference by large cap pharmaceutical companies concerning upcoming events...
Published:
Merrill Lynch likes the health care sector and has made no secret that they think that it can continue to outperform for the balance of 2014. Here are some of the top health care names to buy now...
Published:
Most Wall Street firms run model portfolios for their institutional and retail clients. Here are stocks that recently were added to the Piper Jaffray Model Portfolio.
Published:
Novartis announced Monday morning that it will acquire privately held startup biotech CoStim Pharmaceuticals. Terms of the deal were not revealed, but it will bolster Novartis's cancer immunotherapy...
Published:
With top biotechnology and health care companies from around the world attending the Leerink Global Healthcare, it is a good chance for investors to get timely updates on the top stocks and their...
Published:
Ariad Pharmaceuticals could be joining the ranks of the next big biotech acquisitions. The company fits the bill of many biotech acquirers because its market cap is just over $1 billion and its...
Published:
ThinkstockPfizer Inc.’s (NYSE: PFE) patent protecting popular erectile dysfunction drug Viagra from generic competition may not expire until April 2020, but Teva Pharmaceutical Industries Ltd....
Published:
Jon OggNow that we are mostly through earnings season and now that stocks have challenged all-time highs recently, investors and traders alike have to start thinking about how to position themselves...
Published:
courtesy Deere & Co.UBS has a list of stocks that investors may want to consider selling. They could even be a list of short sale candidates. The UBS team is bashing Apache Corp. (NYSE: APA),...
Published:
courtesy of AOL, IncHeading into the fourth quarter of this year, investors who have been long the stock market are poised for the best gains since the market exploded off the lows in 2009. While the...
Published:
Jon OggA new earnings season has started, and stocks and bonds are dealing with a likely patch for the government shutdown and the debt ceiling. So which are the stocks to buy and which the stocks to...
Published:
ThinkstockThe drug and pharmaceutical sector is supposed to be a defensive one by nature, even if this week’s government shutdown and impending debt ceiling weighed heavily on biotech stocks....
Published: